Citadel Advisors’s Aemetis AMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225K Sell
70,600
-58,300
-45% -$106K ﹤0.01% 11167
2025
Q4
$179K Buy
128,900
+50,600
+65% +$102K ﹤0.01% 11128
2025
Q3
$176K Buy
78,300
+8,200
+12% +$21.8K ﹤0.01% 11391
2025
Q2
$174K Sell
70,100
-38,500
-35% -$65.1K ﹤0.01% 10815
2025
Q1
$189K Sell
108,600
-8,700
-7% -$18.6K ﹤0.01% 10532
2024
Q4
$316K Sell
117,300
-25,000
-18% -$78.6K ﹤0.01% 9552
2024
Q3
$327K Buy
142,300
+14,400
+11% +$40.4K ﹤0.01% 9149
2024
Q2
$385K Buy
127,900
+29,300
+30% +$112K ﹤0.01% 8602
2024
Q1
$591K Sell
98,600
-113,400
-53% -$430K ﹤0.01% 8010
2023
Q4
$1.11M Sell
212,000
-41,000
-16% -$194K ﹤0.01% 6468
2023
Q3
$1.05M Buy
253,000
+41,100
+19% +$251K ﹤0.01% 6464
2023
Q2
$1.55M Buy
211,900
+160,900
+315% +$611K ﹤0.01% 5622
2023
Q1
$118K Sell
51,000
-9,900
-16% -$36.9K ﹤0.01% 11019
2022
Q4
$241K Buy
60,900
+27,100
+80% +$154K ﹤0.01% 9765
2022
Q3
$207K Sell
33,800
-26,400
-44% -$201K ﹤0.01% 10335
2022
Q2
$296K Sell
60,200
-18,100
-23% -$158K ﹤0.01% 9822
2022
Q1
$992K Buy
78,300
+47,000
+150% +$518K ﹤0.01% 7706
2021
Q4
$385K Sell
31,300
-53,800
-63% -$950K ﹤0.01% 10314
2021
Q3
$1.56M Buy
85,100
+28,600
+51% +$316K ﹤0.01% 7000
2021
Q2
$631K Sell
56,500
-223,900
-80% -$3.53M ﹤0.01% 9490
2021
Q1
$6.88M Buy
280,400
+170,200
+154% +$1.9M ﹤0.01% 3621
2020
Q4
$274K Buy
+110,200
New +$335K ﹤0.01% 9221

Other funds holding AMTX

Citadel Advisors's AMTX Position: Q1 2026 in Review

Citadel Advisors reduced its Aemetis (AMTX) stake by 5.8% in Q1 2026, selling an estimated $52.6K and leaving 469,715 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #6712.

Citadel Advisors first reported a position in AMTX in Q3 2016 and has held it in 29 quarters since. The position peaked at $5.86M in Q1 2021. 78 funds tracked by Wall St. Rank hold AMTX as of Q1 2026.

  • Citadel Advisors held 469,715 shares of Aemetis worth $1.5M as of Q1 2026.
  • Citadel Advisors sold 28,913 Aemetis shares in Q1 2026, an estimated $52.6K.
  • Aemetis made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6712 holding.
  • Citadel Advisors first reported a position in Aemetis in Q3 2016 and has held it in 29 quarters since.
  • Citadel Advisors's Aemetis position peaked at $5.86M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Aemetis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.